US health officials on Tuesday gave the final signoff to Pfizer’s kid-size COVID-19 shot, a major expansion of the nation’s vaccination campaign.
The Food and Drug Administration already authorized the shots for children ages 5 to 11 — doses just a third of the amount given to teens and adults.
But the Centers for Disease Control and Prevention recommends who should receive FDA-cleared vaccines.
The announcement by CDC director Dr. Rochelle Walensky came only hours after an advisory panel unanimously decided Pfizer’s shots should be opened to the 28 million youngsters in that age group.
Millions of shots made by Pfizer and its partner BioNTech have already been shipped to states, doctors’ offices and pharmacies, to be ready for CDC’s decision.
COVID-19 vaccine: US CDC expands booster rollout, OKs mixing shotsMillions more Americans can get a COVID-19 booster and choose a different company’s vaccine for that next shot, federal health officials said Thursday ... Coronavirus
Pfizer COVID-19 vaccine highly protective in 12-18 age group: US CDCThe Pfizer Inc/BioNTech SE COVID-19 vaccine was 93 percent effective in preventing hospitalizations among those aged 12 to 18, according to an ... Coronavirus